MRI Guided Prostate Biopsy for Prostate Cancer Diagnosis: Now Available at University Hospitals

University Hospitals offers a prostate biopsy procedure guided by magnetic resonance imaging (MRI) technology. This leading-edge diagnostic tool for prostate cancer is much more efficient than a traditional biopsy and causes less discomfort. In some cases, you can receive a diagnosis and treatment plan in as little as a day.

Schedule Your Visit with a UH Urologist Today

To learn more about University Hospitals advanced prostate diagnostic tests, or to schedule an appointment, call us at 1-866-844-2273.

UH is dedicated to advancing men's health through faster, easier and more accurate prostate cancer diagnosis — for reduced anxiety and a better experience overall.

Part of a research grant through the National Institutes of Health (NIH), our team at University Hospitals was an important part of this unique discovery – which is now available at UH for our patients across Northeast Ohio. It’s just one of the ways UH is researching, developing and delivering new and advanced patient care with these MRIs for prostate cancer screening.

Advanced Magnetic Resonance Mapping Targets Cancer

Using a cutting-edge technique for prostate cancer diagnosis and management, our team at University Hospitals uses MRI mapping to identify the exact location of suspicious tissue. We use images from the MRI to distinguish abnormal tissue from normal tissue. This allows our physicians to more accurately identify prostate cancer tumors and lesions, while also tracking their growth.

Although historically believed that MRI machines couldn’t detect cancerous tissue, we now know that MRI images accurately identify aggressive cancers. So, with this knowledge, UH physicians developed the non-invasive “fingerprinting” technique to map the prostate and help distinguish normal from abnormal prostate tissue.

This breakthrough procedure lets UH physicians also monitor the prostate without making men go through unnecessary biopsies or other invasive examinations. As part of our active surveillance treatment, our team is able to monitor the growth of the tumor and determine if more interventional prostate cancer treatment is needed.

Future benefits may be even brighter: University Hospitals has been awarded a $5 million grant from the National Institutes of Health to further develop MRI mapping and the use of artificial intelligence to predict the likelihood of a cancer diagnosis.

Pinpointing Tumor Location for More Accurate Diagnosis

Transrectal ultrasound (TRUS) guided biopsy is the standard test used to diagnose prostate cancer. This test can show the size and shape of the prostate gland, but not the exact shape and location of a tumor. As a result, up to 12 tissue samples usually have to be taken. In addition to discomfort and risks of bleeding and other complications, this testing method also has false-negative rates of up to 30 percent.

That’s why UH now uses this new way to conduct a prostate biopsy inside an MRI machine, or “in gantry.” Available at only a few other places nationwide, UH physicians use MRI technology to pinpoint the location of tumors. In this way, our team is able to biopsy the diseased tissue identified by the MRI rather than taking a greater number of random prostate tissue samples - in hopes of finding the cancer. Our team just needs one to three core samples, which means a more efficient procedure and faster diagnosis for you.

Men most likely to benefit from an in-gantry MRI-guided biopsy include those suspected of having prostate cancer, but who have inconclusive tests results and any of these circumstances:

  • Persistent, unexplained elevated PSA
  • Prior negative biopsy
  • Increased prostate cancer gene expression
  • Low-risk prostate cancer being monitored by active surveillance, or watchful waiting